APOG

Latest SEC Filings & News for APOG

5 most recent filings and news items mentioning APOG. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/APOG/news?limit=20"

Pull APOG filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Apogee Enterprises completes acquisition of Kalwall for up to $115 million.

Apogee Enterprises announced the completion of its acquisition of Kalwall Companies from the Keller family for up to $115 million. This strategic transaction strengthens Apogee's market position by integrating differentiated daylighting capabilities and a strong architectural bra

View filing at SEC.gov →

Apogee Reports Q1 FY27 Results, Reaffirms Guidance

Apogee Enterprises reported a significant increase in earnings and gross margin for its first fiscal quarter of 2027. Management reaffirmed fiscal 2027 guidance while maintaining a disciplined approach to capital allocation.

View filing at SEC.gov →

Nasdaq Falls For Fourth Day Amid Decline In Apple Shares: Investor Sentiment Declines, Greed Index Remains In ‘Fear’ Zone

Nasdaq Falls For Fourth Day Amid Decline In Apple Shares: Investor Sentiment Declines, Greed Index Remains In ‘Fear’ Zone

View filing at SEC.gov →

AbbVie to acquire Apogee Therapeutics in merger agreement dated June 18, 2026

AbbVie Inc. has entered into a definitive merger agreement to acquire Apogee Therapeutics, Inc. through a subsidiary merger structure. The transaction expands AbbVie's therapeutic pipeline and represents a significant M&A activity in the pharmaceutical sector.

View filing at SEC.gov →

Apogee enters antibody discovery agreement with Paragon Therapeutics

Apogee Therapeutics signed an Antibody Discovery Agreement with Paragon Therapeutics effective June 17, 2026, for discovery and development of monospecific antibody candidates. The agreement includes a concurrent License Agreement enabling Apogee to further develop, manufacture a

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.